Search Clinical Trials
597,157 trials
ID
Status
Phase
Title
Sponsor
NCT07750704
Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLCGuangdong Association of Clinical TrialsNot Yet RecruitingPhase 2
NCT07750704Not Yet Recruiting
Phase 2
Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-...Guangdong Association of...
NCT07750548
sirA-CPB Strategy Reduces New Ischemic/Embolic Lesions After Acute Type A Aortic Dissection SurgeryXiangya Hospital of Central South UniversityNot Yet RecruitingNot Applicable
NCT07750548Not Yet Recruiting
Not Applicable
sirA-CPB Strategy Reduces New Ischemic/Embolic Lesions After Acute Type A Aortic...Xiangya Hospital of Centr...
NCT07749157
A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple SclerosisHoffmann-La RocheNot Yet RecruitingPhase 1
NCT07749157Not Yet Recruiting
Phase 1
A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing...Hoffmann-La Roche
NCT07750041
A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal CancerCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07750041Not Yet Recruiting
Phase 1
A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal CancerCSPC Megalith Biopharmace...
NCT07748988
Pilot Study of Casdatifan-Treated Refractory Renal Cell CarcinomaArcus Biosciences, Inc.Not Yet RecruitingEarly Phase 1
NCT07748988Not Yet Recruiting
Early Phase 1
Pilot Study of Casdatifan-Treated Refractory Renal Cell CarcinomaArcus Biosciences, Inc.
NCT07749872
KAP TB in Senior Management Officials of Companies With Increased Silica ExposureCentre for Infectious Disease Research in ZambiaCompleted
NCT07749872Completed
—
KAP TB in Senior Management Officials of Companies With Increased Silica Exposur...Centre for Infectious Dis...
NCT07750301
Development, Implementation, and Evaluation of the HADAS Program for the Prevention of Eating Disorders in Adolescent Female Athletes, Coaches, and Families.Universidad Miguel Hernandez de ElcheNot Yet RecruitingNot Applicable
NCT07750301Not Yet Recruiting
Not Applicable
Development, Implementation, and Evaluation of the HADAS Program for the Prevent...Universidad Miguel Hernan...
NCT07750613
Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable COPDADIR AssociationNot Yet RecruitingNot Applicable
NCT07750613Not Yet Recruiting
Not Applicable
Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therap...ADIR Association
NCT07750626
Effect of Vibration and ShotBlocker on Pain and Fear Levels During Intramuscular Injection in Children in the Emergency DepartmentBurdur Mehmet Akif Ersoy UniversityRecruitingNot Applicable
NCT07750626Recruiting
Not Applicable
Effect of Vibration and ShotBlocker on Pain and Fear Levels During Intramuscular...Burdur Mehmet Akif Ersoy...
NCT07749612
ZEPU-2000 Limb Rehabilitation Trainer Study (ZEPU2000RCT)Bangladesh Medical UniversityNot Yet RecruitingNot Applicable
NCT07749612Not Yet Recruiting
Not Applicable
ZEPU-2000 Limb Rehabilitation Trainer Study (ZEPU2000RCT)Bangladesh Medical Univer...
NCT07750015
Derivation and External Validation of the "FORECAST-PC" Prediction ScoresDr. med. Alexander Salerno, MD-PhDCompleted
NCT07750015Completed
—
Derivation and External Validation of the "FORECAST-PC" Prediction ScoresDr. med. Alexander Salern...
NCT07748702
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy VolunteersChong Kun Dang PharmaceuticalNot Yet RecruitingPhase 1
NCT07748702Not Yet Recruiting
Phase 1
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy...Chong Kun Dang Pharmaceut...
NCT07748936
Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot StudyCentre Hospitalier Universitaire DijonNot Yet RecruitingNot Applicable
NCT07748936Not Yet Recruiting
Not Applicable
Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot StudyCentre Hospitalier Univer...
NCT07750743
Temporomandibular Disorders With and Without Chronic Neck PainHacettepe UniversityCompleted
NCT07750743Completed
—
Temporomandibular Disorders With and Without Chronic Neck PainHacettepe University
NCT07749859
SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular CarcinomaCancer Institute and Hospital, Chinese Academy of Medical SciencesNot Yet RecruitingPhase 2
NCT07749859Not Yet Recruiting
Phase 2
SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated A...Cancer Institute and Hosp...
NCT07749807
Nebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNLBenha UniversityNot Yet RecruitingNot Applicable
NCT07749807Not Yet Recruiting
Not Applicable
Nebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNLBenha University
NCT07748780
Testing a Blended Social-Communication and Social-Emotional Intervention for Autistic ToddlersBaylor UniversityNot Yet RecruitingNot Applicable
NCT07748780Not Yet Recruiting
Not Applicable
Testing a Blended Social-Communication and Social-Emotional Intervention for Aut...Baylor University
NCT07750847
Impact of Presenting Symptoms on Treatment Time and Outcomes in Acute Ischemic StrokeAssiut UniversityNot Yet Recruiting
NCT07750847Not Yet Recruiting
—
Impact of Presenting Symptoms on Treatment Time and Outcomes in Acute Ischemic S...Assiut University
NCT07750483
Efficacy of Intra-Articular Hyaluronic Acid Combination Injections for Temporomandibular Joint Internal Derangement: A Clinical and MRI Based Randomized TrialMansoura UniversityCompletedNot Applicable
NCT07750483Completed
Not Applicable
Efficacy of Intra-Articular Hyaluronic Acid Combination Injections for Temporoma...Mansoura University
NCT07750132
Phase I Study of SM2275 Injection in Patients With Advanced Solid TumorsBeijing StarMab Biomed Technology LtdNot Yet RecruitingPhase 1
NCT07750132Not Yet Recruiting
Phase 1
Phase I Study of SM2275 Injection in Patients With Advanced Solid TumorsBeijing StarMab Biomed Te...
Result Breakdown
Not yet recruiting15 (75%)
Completed4 (20%)
Recruiting1 (5%)
not_applicable9 (45%)
Phase 14 (20%)
Not Specified4 (20%)
Phase 22 (10%)
Early Phase 11 (5%)